PVI
ISEE

Pura Vida Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pura Vida Investments’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,700
Closed -$422K – 195
2022
Q4 		$422K Sell
19,700
-14,300
-42% -$305K 0.02% 169
2022
Q3 		$610K Hold
34,000
– – 0.04% 170
2022
Q2 		$327K Hold
34,000
– – 0.02% 185
2022
Q1 		$572K Buy
34,000
+14,400
+73% +$213K 0.02% 200
2021
Q4 		$328K Sell
19,600
-600
-3% -$9.83K 0.01% 219
2021
Q3 		$328K Buy
+20,200
New +$220K 0.01% 262

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pura Vida Investments's ISEE Position: Q1 2023 in Review

Pura Vida Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 1,182,975 shares — an estimated $25.3M sold.

Pura Vida Investments first reported a position in ISEE in Q1 2016 and held it in 10 quarters. The position peaked at $25.3M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Pura Vida Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 1,182,975 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $25.3M.
  • Pura Vida Investments first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 10 quarters.
  • Pura Vida Investments's IVERIC bio, Inc. Common Stock position peaked at $25.3M in Q4 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.